Archives

by in
Entry Author Date Location
Five Questions: Acorda CEO Ron Cohen on the Future of Neurology R&D 04/17/12 New York
Provid Pharma Leans on MS Society’s Venture Fund to Boost Lead Drug 04/12/12 New York
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
Transparency Launches as Linux of Drug Development 02/23/12 New York
Angry at the Genome 01/25/12 Boston
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan 01/03/12 Seattle
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles 12/23/11 Seattle
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Genzyme MS Drug Significantly Reduces Relapse, Disability in Late-Stage Trial 11/14/11 Boston
Today’s Xconomy Report: Biogen Idec Meets Goals in Clinical Trial, iRobot Layoffs, $1M Awarded by MassChallenge, and Bay State Venture Capital Earnings 10/28/11 Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
Biogen Idec’s Oral Multiple Sclerosis Drug Passes 2nd Major Test; Stock Soars 10/26/11 Boston
Sha Mi, Biogen Idec’s Neurology Ace, to Join “The Genetics Institute Impact” on Dec. 14 10/21/11 Boston
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO 07/13/11 Seattle
Coronado Biosciences Pulls in $25.8 Million 07/06/11 New York
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ 06/22/11 Seattle
Biogen Idec CEO on Move Back to Cambridge: “We’re Working on It” 06/16/11 Boston
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
Biogen Gets EU Panel OK for MS Drug 05/20/11 Boston
Alkermes Acquires Elan Drug Manufacturing Unit for $960M 05/09/11 Boston
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Biogen Shares Jump on Good News on Revenue, Oral MS Drug 04/21/11 Boston
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public 04/21/11 Boston
Acorda Issued Patent on MS Drug Following Days of Speculation 04/19/11 New York
Aveo Adds Termeer to Board, Monsanto Partners With Atlas, Biogen Drug Meets Clinical Goal, & More Boston-Area Life Sciences News 04/15/11 Boston
Acorda Stock Halted as Shares Skyrocket on Patent Speculation 04/14/11 New York
Biogen Idec Passes Pivotal Trial With Oral MS Drug; Shares Climb 04/11/11 Boston
Experience Project Launches BroadCause, Putting Social Media to Work for Charitable Causes—and the Corporations Backing Them 04/05/11 San Francisco
Genzyme-Spinout Peptimmune Files for Chapter 7 Liquidation 03/23/11 Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News 03/04/11 Boston
Page 2 of 7 « previous page · next page »